Literature DB >> 12746905

Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.

Rebecca Wing-Yan Chan1, Lai-Shan Tam, Edmund Kwok-Ming Li, Fernand Mac-Moune Lai, Kai-Ming Chow, Ka-Bik Lai, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

OBJECTIVE: Lupus nephritis is characterized by intrarenal inflammation and lymphocyte activation. In the present study, the expression of cytokine genes in the urinary sediment of patients with systemic lupus erythematosus (SLE) was examined.
METHODS: We studied 3 SLE patient groups (25 with active lupus nephritis [active group], 25 with inactive SLE and previous renal involvement [remission group], 20 with inactive SLE and no history of renal involvement [nonrenal SLE group]) and 2 control groups (10 patients with noninflammatory renal diseases [non-SLE group] and 10 healthy volunteers [healthy group]). Cytokine gene expression in the urinary sediment was studied by real-time quantitative polymerase chain reaction.
RESULTS: Expression of interferon-gamma (IFNgamma) in urinary sediment was significantly higher in the active group than in all other groups (P < 0.001 by Kruskal-Wallis test). Among the SLE patient groups, there was a close correlation between IFNgamma expression and the overall SLE Disease Activity Index (SLEDAI) score (Spearman's r = 0.590, P < 0.001) and the SLEDAI renal score (r = 0.642, P < 0.001). Urinary expression of interleukin-2 (IL-2) in the active group was significantly higher than that in the healthy group (P = 0.046) but not in the remission or nonrenal SLE groups. There was no difference in the levels of IL-4 expression among the SLE groups.
CONCLUSION: We found a predominance of Th1 cytokine in the urinary sediment of patients with active lupus nephritis. Measurement of cytokine gene expression in urinary sediment may be a useful noninvasive tool for assessing the severity of renal involvement in SLE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746905     DOI: 10.1002/art.11062

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

Review 1.  Treatment of proliferative lupus nephritis: a slowly changing landscape.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Nat Rev Nephrol       Date:  2010-12-21       Impact factor: 28.314

2.  Differential efficacy of human mesenchymal stem cells based on source of origin.

Authors:  Erin Collins; Fei Gu; Maosong Qi; Ivan Molano; Phillip Ruiz; Lingyun Sun; Gary S Gilkeson
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

3.  Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.

Authors:  Tamar Aprahamian; Ramon Bonegio; Jennifer Rizzo; Harris Perlman; David J Lefer; Ian R Rifkin; Kenneth Walsh
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

Authors:  L C W Lit; C K Wong; L S Tam; E K M Li; C W K Lam
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

5.  Intrarenal cytokine gene expression in lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Kai-Ming Chow; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

6.  Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis.

Authors:  Koji Tsugawa; Eishin Oki; Koichi Suzuki; Tadaatsu Imaizumi; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

7.  Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

Authors:  C K Wong; P T Y Wong; L S Tam; E K Li; D P Chen; C W K Lam
Journal:  Clin Exp Immunol       Date:  2009-10-16       Impact factor: 4.330

8.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

9.  Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.

Authors:  Tianfu Wu; Yuyang Fu; Deirdre Brekken; Mei Yan; Xin J Zhou; Kamala Vanarsa; Nima Deljavan; Chul Ahn; Chaim Putterman; Chandra Mohan
Journal:  J Immunol       Date:  2010-01-11       Impact factor: 5.422

10.  Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.

Authors:  Jien-Wen Chien; Woan-Ling Chen; Yi-Giien Tsui; Min-Chun Lee; An-Yi Lin; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2006-03-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.